Hecong Qin1, Vickie Zhang2, Robert A Bok2, Romelyn Delos Santos2, J Adam Cunha3, I-Chow Hsu3, Justin Delos Santos Bs2, Jessie E Lee2, Subramaniam Sukumar2, Peder E Z Larson1, Daniel B Vigneron1, David M Wilson2, Renuka Sriram2, John Kurhanewicz4. 1. Department of Radiology and Biomedical Imaging, University of California, San Francisco, California; Graduate Program in Bioengineering, University of California, Berkeley and University of California, San Francisco, California. 2. Department of Radiology and Biomedical Imaging, University of California, San Francisco, California. 3. Department of Radiation Oncology, University of California, San Francisco, California. 4. Department of Radiology and Biomedical Imaging, University of California, San Francisco, California; Graduate Program in Bioengineering, University of California, Berkeley and University of California, San Francisco, California. Electronic address: john.kurhanewicz@ucsf.edu.
Abstract
PURPOSE: To investigate use of a novel imaging approach, hyperpolarized (HP) 13C magnetic resonance imaging (MRI) for simultaneous metabolism and perfusion assessment, to evaluate early and dose-dependent response to radiation therapy (RT) in a prostate cancer mouse model. METHODS AND MATERIALS: Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice (n = 18) underwent single-fraction RT (4-14 Gy steep dose across the tumor) and were imaged serially at pre-RT baseline and 1, 4, and 7 days after RT using HP 13C MRI with combined [1-13C]pyruvate (metabolic active agent) and [13C]urea (perfusion agent), coupled with conventional multiparametric 1H MRI including T2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging. Tumor tissues were collected 4 and 7 days after RT for biological correlative studies. RESULTS: We found a significant decrease in HP pyruvate-to-lactate conversion in tumors responding to RT, with concomitant significant increases in HP pyruvate-to-alanine conversion and HP urea signal; the opposite changes were observed in tumors resistant to RT. Moreover, HP lactate change was dependent on radiation dose; tumor regions treated with higher radiation doses (10-14 Gy) exhibited a greater decrease in HP lactate signal than low-dose regions (4-7 Gy) as early as 1 day post-RT, consistent with lactate dehydrogenase enzyme activity and expression data. We also found that HP [13C]urea MRI provided assessments of tumor perfusion similar to those provided by 1H dynamic contrast-enhanced MRI in this animal model. However, apparent diffusion coefficien , a conventional 1H MRI functional biomarker, did not exhibit statistically significant changes within 7 days after RT. CONCLUSION: These results demonstrate the ability of HP 13C MRI to monitor radiation-induced physiologic changes in a timely and dose-dependent manner, providing the basic science premise for further clinical investigation and translation.
PURPOSE: To investigate use of a novel imaging approach, hyperpolarized (HP) 13C magnetic resonance imaging (MRI) for simultaneous metabolism and perfusion assessment, to evaluate early and dose-dependent response to radiation therapy (RT) in a prostate cancermouse model. METHODS AND MATERIALS: Transgenic Adenocarcinoma of Mouse Prostate (TRAMP) mice (n = 18) underwent single-fraction RT (4-14 Gy steep dose across the tumor) and were imaged serially at pre-RT baseline and 1, 4, and 7 days after RT using HP 13C MRI with combined [1-13C]pyruvate (metabolic active agent) and [13C]urea (perfusion agent), coupled with conventional multiparametric 1H MRI including T2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging. Tumor tissues were collected 4 and 7 days after RT for biological correlative studies. RESULTS: We found a significant decrease in HP pyruvate-to-lactate conversion in tumors responding to RT, with concomitant significant increases in HP pyruvate-to-alanine conversion and HP urea signal; the opposite changes were observed in tumors resistant to RT. Moreover, HP lactate change was dependent on radiation dose; tumor regions treated with higher radiation doses (10-14 Gy) exhibited a greater decrease in HP lactate signal than low-dose regions (4-7 Gy) as early as 1 day post-RT, consistent with lactate dehydrogenase enzyme activity and expression data. We also found that HP [13C]urea MRI provided assessments of tumor perfusion similar to those provided by 1H dynamic contrast-enhanced MRI in this animal model. However, apparent diffusion coefficien , a conventional 1H MRI functional biomarker, did not exhibit statistically significant changes within 7 days after RT. CONCLUSION: These results demonstrate the ability of HP 13C MRI to monitor radiation-induced physiologic changes in a timely and dose-dependent manner, providing the basic science premise for further clinical investigation and translation.
Authors: Mack Roach; Gerald Hanks; Howard Thames; Paul Schellhammer; William U Shipley; Gerald H Sokol; Howard Sandler Journal: Int J Radiat Oncol Biol Phys Date: 2006-07-15 Impact factor: 7.038
Authors: Kayvan R Keshari; David M Wilson; Mark Van Criekinge; Renuka Sriram; Bertram L Koelsch; Zhen J Wang; Henry F VanBrocklin; Donna M Peehl; Tom O'Brien; Deepak Sampath; Richard A D Carano; John Kurhanewicz Journal: Prostate Date: 2015-07-14 Impact factor: 4.104
Authors: Jessie E Lee; Chris J Diederich; Robert Bok; Renuka Sriram; Romelyn Delos Santos; Susan M Noworolski; Vasant A Salgaonkar; Matthew S Adams; Daniel B Vigneron; John Kurhanewicz Journal: NMR Biomed Date: 2018-07-18 Impact factor: 4.044
Authors: Kinan Alhallak; Samir V Jenkins; David E Lee; Nicholas P Greene; Kyle P Quinn; Robert J Griffin; Ruud P M Dings; Narasimhan Rajaram Journal: J Biomed Opt Date: 2017-06-01 Impact factor: 3.170
Authors: Hecong Qin; Shuyu Tang; Andrew M Riselli; Robert A Bok; Romelyn Delos Santos; Mark van Criekinge; Jeremy W Gordon; Rahul Aggarwal; Rui Chen; Gregory Goddard; Chunxin Tracy Zhang; Albert Chen; Galen Reed; Daniel M Ruscitto; James Slater; Renuka Sriram; Peder E Z Larson; Daniel B Vigneron; John Kurhanewicz Journal: Magn Reson Med Date: 2021-08-10 Impact factor: 3.737